Literature DB >> 30587036

Comparison of blood serum protein analysis by MALDI-MS from either conventional frozen samples or storage disc-deposited samples: A study with human serum from pregnant donors and from patients with intrauterine growth restriction.

Manja Wölter1, Manuela Russ1, Charles A Okai1, Werner Rath2, Ulrich Pecks2, Michael O Glocker1.   

Abstract

Mass spectrometric profiling of intact serum proteins, i.e. determination of relative protein abundance differences, was performed using two different serum sample preparation methods: one with frozen and thawed serum, the other with at room temperature deposited and dried serum. Since in a typical clinical setting freezing of serum is difficult to achieve, sampling at room temperature is preferred and can be met when using the Noviplex™ card system. Once deposited and dried, serum proteins can be stored and shipped at room temperature. After resolubilization of serum proteins from "dried serum spots", mass spectra of high quality have been recorded comparable to those that were obtained using fresh-frozen and subsequently thawed serum samples. Differentiation between patients with intrauterine growth restriction and control individuals was achievable, independent from the sample work-up procedure. Having at hand a reliable and robust method for serum storage and shipment which works at room temperature bridges the gap between the clinics and the protein analysis laboratory. Our novel serum handling protocol reduces costs for both, storage and shipping, and ultimately enables clinical risk assessment based on mass spectrometric determination of intact protein abundance profiles.

Entities:  

Keywords:  Dried serum spots; MALDI-ToF-MS; apolipoproteins; pregnancy complications; proteome profiling

Mesh:

Substances:

Year:  2018        PMID: 30587036     DOI: 10.1177/1469066718820991

Source DB:  PubMed          Journal:  Eur J Mass Spectrom (Chichester)        ISSN: 1469-0667            Impact factor:   1.067


  1 in total

1.  Precision Diagnostics by Affinity-Mass Spectrometry: A Novel Approach for Fetal Growth Restriction Screening During Pregnancy.

Authors:  Charles A Okai; Manuela Russ; Manja Wölter; Kristin Andresen; Werner Rath; Michael O Glocker; Ulrich Pecks
Journal:  J Clin Med       Date:  2020-05-07       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.